Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,967Revenue $M3,050Net Margin (%)22.6Z-Score4.2
Enterprise Value $M11,432EPS $8.4Operating Margin %39.8F-Score7
P/E(ttm))15.3Cash Flow Per Share $8.0Pre-tax Margin (%)39.8Higher ROA y-yY
Price/Book5.410-y EBITDA Growth Rate %13.9Quick Ratio3.0Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %19.5Current Ratio3.7Lower Leverage y-yY
Price/Cash Flow12.2y-y EBITDA Growth Rate %83.3ROA % (ttm)13.7Higher Current Ratio y-yN
Dividend Yield %0.6Insider Buy (3m)0ROE % (ttm)33.0Less Shares Outstanding y-yY
Payout Ratio %9.0Shares Outstanding M76.3ROI % (ttm)5.1Gross Margin Increase y-yN

Gurus Latest Trades with BCR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 145.922%Reduce -2.76%3,330,000
BCRVanguard Health Care Fund 2014-03-31 Add0.63%$125.42 - $146.57
($137.91)
$ 145.926%Add 505.6%1,839,200
BCRRay Dalio 2014-03-31 Add0.03%$125.42 - $146.57
($138.12)
$ 145.926%Add 118.27%43,186
BCRYacktman Focused Fund 2014-03-31 Reduce-0.91%$125.42 - $146.57
($137.91)
$ 145.926%Reduce -21.67%2,350,000
BCRDonald Yacktman 2014-03-31 Reduce-0.51%$125.42 - $146.57
($137.91)
$ 145.926%Reduce -11.96%6,827,627
BCRVanguard Health Care Fund 2013-12-31 Buy 0.13%$113.84 - $139.85
($132.09)
$ 145.9210%New holding, 303700 sh.303,700
BCRYacktman Focused Fund 2013-12-31 Reduce-1.7%$113.84 - $139.85
($132.09)
$ 145.9210%Reduce -29.91%3,000,000
BCRDonald Yacktman 2013-12-31 Reduce-1.09%$113.84 - $139.85
($132.09)
$ 145.9210%Reduce -21.46%7,755,464
BCRYacktman Fund 2013-12-31 Reduce-0.45%$113.84 - $139.85
($132.09)
$ 145.9210%Reduce -9.89%3,500,000
BCRRay Dalio 2013-12-31 Reduce-0.01%$113.84 - $139.85
($132.09)
$ 145.9210%Reduce -30.54%19,786
BCRRay Dalio 2013-09-30 Add0.01%$107.3 - $120.55
($114.78)
$ 145.9227%Add 24.47%28,486
BCRJeff Ubben 2013-09-30 Sold Out -0.85%$107.3 - $120.55
($114.78)
$ 145.9227%Sold Out0
BCRJoel Greenblatt 2013-09-30 Reduce-0.07%$107.3 - $120.55
($114.78)
$ 145.9227%Reduce -47.69%15,933
BCRYacktman Focused Fund 2013-06-30 Add1.26%$98.25 - $111.8
($104.06)
$ 145.9240%Add 27.8%4,280,000
BCRYacktman Fund 2013-06-30 Add1.06%$98.25 - $111.8
($104.06)
$ 145.9240%Add 29.9%3,884,100
BCRDonald Yacktman 2013-06-30 Add1%$98.25 - $111.8
($104.06)
$ 145.9240%Add 24.46%9,973,185
BCRJoel Greenblatt 2013-06-30 Add0.03%$98.25 - $111.8
($104.06)
$ 145.9240%Add 25.09%30,459
BCRJeff Ubben 2013-06-30 Reduce-3.24%$98.25 - $111.8
($104.06)
$ 145.9240%Reduce -79.02%758,704
BCRRay Dalio 2013-06-30 Reduce-0.04%$98.25 - $111.8
($104.06)
$ 145.9240%Reduce -65.99%22,886
BCRYacktman Focused Fund 2013-03-31 Add0.36%$97.74 - $103.51
($100.89)
$ 145.9245%Add 8.36%3,348,994
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BCR Yacktman Focused Fund 2014-06-302,300,0003.023.3-2.13%
BCR Yacktman Fund 2014-06-303,330,0004.374.1-2.76%
BCR Vanguard Health Care Fund 2014-03-311,839,2002.410.76+505.6%
BCR Ray Dalio 2014-03-3143,1860.060.05+118.27%
BCR Joel Greenblatt 2014-03-3113,9840.020.03-1.19%
BCR Donald Yacktman 2014-03-316,827,6278.954.2-11.96%
Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RING TIMOTHY MChairman and CEO 2014-07-01Sell10,231$144.3-0.33view
RING TIMOTHY MChairman and CEO 2014-06-02Sell10,231$147.5-2.49view
RING TIMOTHY MChairman and CEO 2014-05-01Sell10,231$137.24.83view
RING TIMOTHY MChairman and CEO 2014-04-01Sell10,231$149.22-3.62view
RING TIMOTHY MChairman and CEO 2014-03-03Sell10,231$142.231.12view
Luboff Sharon MGroup Vice President 2014-02-27Sell9,914$144.86-0.72view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-02-26Sell7,359$142.790.72view
KELLY BRONWEN KVP - Human Resources 2014-02-25Sell2,917$141.991.29view
RING TIMOTHY MChairman and CEO 2014-02-24Sell6,760$142.850.68view
Lupisella Frank JrVice President and Controller 2014-02-20Sell2,520$140.262.54view

Press Releases about BCR :

    Quarterly/Annual Reports about BCR:

    News about BCR:

    Articles On GuruFocus.com
    Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
    CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
    Yacktman Funds Comments on C.R. Bard Inc. Mar 12 2014 
    Yacktman Fund Comments on C.R. Bard Inc. Jan 30 2014 
    Yacktman Focused Fund & Yacktman Fund Fourth Quarter Commentary Jan 30 2014 
    Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK Jan 20 2014 
    Yacktman Fund Buys Oracle, Exxon Mobil, C.R. Bard, Sells Pfizer, Viacom, Microsoft Jul 17 2013 
    The Yacktman Fund's Top 5 Second Quarter Increases Jul 16 2013 
    My 3 Favorite Stocks with Recent Dividend Growth Jun 16 2013 
    Covidien – Positive Results for Life Jun 09 2013 


    More From Other Websites
    Why Lower-Yielding Stocks Provide Better Long-Term Returns Jul 10 2014
    Bard to Host Earnings Conference Call on July 24, 2014 Jul 01 2014
    3 Stocks Pulling The Health Services Industry Downward Jun 30 2014
    C.R. Bard downgraded by Barclays Jun 18 2014
    Headwinds For C.R. Bard, According To Barclays Jun 18 2014
    Will This Analyst Downgrade Hurt C.R. Bard (BCR) Stock Today? Jun 18 2014
    'Fast Money' Recap: Opening the Oil Spigot? Jun 17 2014
    CR Bard Expands Share Repurchase Program Jun 16 2014
    CR Bard's Lutonix DCB Moves Closer to FDA Clearance Jun 13 2014
    FDA Advisory Panel Supports Novel Drug Coated Balloon Jun 13 2014
    Circulatory System Devices Advisory Panel Provides a Unanimous Favorable Recommendation to FDA for... Jun 12 2014
    Bard Announces $500 Million Share Repurchase Authorization Jun 11 2014
    Bard Increases Quarterly Dividend Jun 11 2014
    3 Stocks Pushing The Health Care Sector Lower Jun 11 2014
    CR Bard (BCR) Shows Signs Of Being Water-Logged And Getting Wetter Jun 10 2014
    C.R. Bard to host analyst meeting May 28 2014
    Cash allowances for CEOs? They're not kids May 24 2014
    C.R. Bard has a conference call hosted by JPMorgan May 12 2014
    Bard to Host Investor Conference May 02 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide